6-Bromo-2-chloro-3-iodopyridine

We are 6-Bromo-2-chloro-3-iodopyridine CAS:1138444-17-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  6-Bromo-2-chloro-3-iodopyridine
CAS.NO:1138444-17-3
Synonyms: 6-Bromo-2-chloro-3-iodopyridine
Pyridine, 6-bromo-2-chloro-3-iodo-
 
Molecular Formula:C5H2BrClIN
Molecular Weight:318.33800
 
Physical and Chemical Properties:
Density:2.4±0.1 g/cm3
Boiling point:316.4±37.0 °C at 760 mmHg
Melting point:/
Flash point:145.2±26.5 °C
Index of Refraction:1.674
 
Specification:
Appearance:Liquid
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

6-Bromo-2-chloro-3-iodopyridine


Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.Glycylglycylglycine On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).2-Chloro-3-fluorobenzaldehyde CAS:96516-31-3 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.

Related Products
Product Name
2-Nitrobenzotrifluoride View Details
5-piperazin-1-yl-1-benzofuran-2-carboxamide View Details
3H-1,3,4-thiadiazole-2-thione View Details
6-Cyano-2-[1-[4-ethyl-3-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-1-methylethyl]-1H-indole-3-carboxylic acid manufacturer N-Methyl-N-Cbz-D-alanine manufacturer 2,4,6-Trimethylbenzoyldi-Phenylphosphinate manufacturer 4-Nitrobenzotrifluoride manufacturer Bis(Diisopropylamino)(2-Cyanoethoxy)Phosphine manufacturer